Logo
    Search

    cgms

    Explore "cgms" with insightful episodes like "#173 - AMA #26: Continuous glucose monitors, zone 2 training, and a framework for interventions", "#54 – Kevin Sayer, CEO of Dexcom: Continuous glucose monitors – impact of food, sleep, and stress on glucose, the unmatched power of CGM to drive behavioral change, and the exciting future of CGM" and "How Cicadas Work" from podcasts like ""The Peter Attia Drive", "The Peter Attia Drive" and "Stuff You Should Know"" and more!

    Episodes (3)

    #173 - AMA #26: Continuous glucose monitors, zone 2 training, and a framework for interventions

    #173 - AMA #26: Continuous glucose monitors, zone 2 training, and a framework for interventions

    In this “Ask Me Anything” (AMA) episode, Peter and Bob answer numerous follow-up questions to recently discussed deep-dive topics such as the use of continuous glucose monitors and getting the most from zone 2 exercise. They also discuss the incredible feats of cyclists in the Tour de France through the lens of the amazing performance physiology required from these athletes. Additionally, Peter ties the conversation together by sharing his foundational framework when considering different interventions, even in the absence of data from a randomized controlled trial.

    If you’re not a subscriber and listening on a podcast player, you’ll only be able to hear a preview of the AMA. If you’re a subscriber, you can now listen to this full episode on your private RSS feed or on our website at the AMA #26 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • Peter’s foundational framework when considering different interventions [1:30];
    • Applying Peter’s framework to the idea of using a CGM [8:00];
    • Why certain fruits have a bigger impact on glucose, and the limitations of a CGM can tell you [16:00];
    • Importance of paying attention to insulin, and the prospects of a continuous monitor for insulin levels [20:00];
    • How exercise impacts glucose and peak glucose numbers to stay under [24:15];
    • Impact of anxiety on stress on glucose, and why it’s important to calibrate your CGM [26:30];
    • The five main tools for managing blood glucose numbers [33:45];
    • Benefits of moving or exercising after a meal, and where ingested carbohydrates get can be stored [37:15];
    • How to make decisions about an action or intervention in the absence of data from a rigorous, randomized controlled trial [40:30];
    • The incredible athletic feats of Tour de France cyclists [48:30];
    • Different modalities for doing zone 2 exercise: running, rowing, cycling, and more [1:00:15];
    • Proxies for knowing your in zone 2 short of using a lactate monitor [1:07:30];
    • Monitoring lactate for zone 2 exercise [1:10:00]; and
    • More.

    Learn more: https://peterattiamd.com/

    Show notes page for this episode: https://peterattiamd.com/ama26/ 

    Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/

    Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/

    Connect with Peter on Facebook | Twitter | Instagram.

     

    #54 – Kevin Sayer, CEO of Dexcom: Continuous glucose monitors – impact of food, sleep, and stress on glucose, the unmatched power of CGM to drive behavioral change, and the exciting future of CGM

    #54 – Kevin Sayer, CEO of Dexcom: Continuous glucose monitors – impact of food, sleep, and stress on glucose, the unmatched power of CGM to drive behavioral change, and the exciting future of CGM

    In this episode, Kevin Sayer, CEO of Dexcom, discusses the remarkable benefits of a continuous glucose monitor for the diabetes population. Peter shares his own invaluable insights he’s learned from wearing a CGM including the impact of sleep and stress on glucose as well as the unmatched power of a CGM to drive behavioral change. Kevin also reveals some of the exciting partnerships and future advancements of their products benefiting not only those with type 1 and 2 diabetes, but also for the growing community of people interested in optimizing health and wellness.

    We discuss:

    • How they met, and Kevin’s path to becoming CEO of Dexcom [7:00];
    • How CGM technology works, and what makes Dexcom’s G6 the best model yet [15:15];
    • Challenges of working in the US healthcare system and getting CGM insured [21:45];
    • Developing an even smaller, more user-friendly, and less costly product while maintaining performance and accuracy [33:15];
    • Next thing on the horizon for type 1 diabetes patients [43:30];
    • The incredible accuracy of the G6, recommended over-the-counter glucose meters, and the unmatched power of CGM to drive behavioral change [48:15];
    • Software improvements for type 2 diabetics, and the remarkable benefits of real-time feedback for driving behavioral change [58:15];
    • Dexcom vs. the competitors, the less invasive options, and the fundamental problems needing to be solved with CGM technologies [1:07:00];
    • The cost of CGM, why you need a prescription, and when might there be a OTC option? [1:12:00];
    • Smartwatch integration, bluetooth technology, and exciting collaborations and partnerships [1:22:00];
    • Future places for CGM: Hospitals, nutrition apps, general health and wellness, and more [1:27:15];
    • Dexcom’s unique company culture [1:34:15];
    • Parenting advice from Kevin [1:37:30];
    • Lessons learned through failures and success [1:38:45]; and
    • More.

    Learn more at www.PeterAttiaMD.com
    Connect with Peter on Facebook | Twitter | Instagram.